Table of Contents Author Guidelines Submit a Manuscript
Cardiology Research and Practice
Volume 2016 (2016), Article ID 1623197, 5 pages
http://dx.doi.org/10.1155/2016/1623197
Research Article

Prevalence of Hepatitis C Virus Seropositivity and Its Impact on Coronary Artery Disease among Egyptian Patients Referred for Coronary Angiography

1Cardiology Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt
2Internal Medicine Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt

Received 15 June 2016; Revised 18 September 2016; Accepted 13 October 2016

Academic Editor: Robert Chen

Copyright © 2016 Ragab Abd El Salam et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. Mohd Hanafiah, J. Groeger, A. D. Flaxman, and S. T. Wiersma, “Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence,” Hepatology, vol. 57, no. 4, pp. 1333–1342, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. F. El-Zanaty and A. Way, “Knowledge and prevalence of hepatitis C,” in Egypt Demographic and Health Survey-2008, chapter 17, pp. 251–258, Ministry of Health, 2009. View at Google Scholar
  3. C. Mathers, C. Bernard, M. Iburg et al., Global burden of disease data sources, methods and results, WHO, 2008, https://apps.who.int/infobase/Comparisons.aspx
  4. A. Gilbert and G. Lion, “Arterites infectieuses experimentales,” C R Hebd Seances Soc Biol Fil, vol. 41, pp. 583–584, 1889. View at Google Scholar
  5. F. R. Stassen, T. Vainas, and C. A. Bruggeman, “Infection and atherosclerosis. An alternative view on an outdated hypothesis,” Pharmacological Reports, vol. 60, no. 1, pp. 85–92, 2008. View at Google Scholar · View at Scopus
  6. R. Zampino, A. Marrone, L. Restivo et al., “Chronic HCV infection and inflammation: clinical impact on hepatic and extra-hepatic manifestations,” World Journal of Hepatology, vol. 5, no. 10, pp. 528–540, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Boddi, R. Abbate, B. Chellini et al., “Hepatitis C virus RNA localization in human carotid plaques,” Journal of Clinical Virology, vol. 47, no. 1, pp. 72–75, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. N. Ishizaka, Y. Ishizaka, E. Takahashi et al., “Association between hepatitis C virus seropositivity, carotid-artery plaque, and intima-media thickening,” The Lancet, vol. 359, no. 9301, pp. 133–135, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. C. Vassalle, S. Masini, F. Bianchi, and G. C. Zucchelli, “Evidence for association between hepatitis C virus seropositivity and coronary artery disease,” Heart, vol. 90, no. 5, pp. 565–566, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. H. Völzke, C. Schwahn, B. Wolff et al., “Hepatitis B and C virus infection and the risk of atherosclerosis in a general population,” Atherosclerosis, vol. 174, no. 1, pp. 99–103, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. A. M. Guiltinan, Z. Kaidarova, B. Custer et al., “Increased all-cause, liver, and cardiac mortality among hepatitis C virus-seropositive blood donors,” American Journal of Epidemiology, vol. 167, no. 6, pp. 743–750, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. S. S. El-Kamary, R. Jhaveri, and M. D. Shardell, “All-cause, liver-related, and non-liver-related mortality among HCV-infected individuals in the general US population,” Clinical Infectious Diseases, vol. 53, no. 2, pp. 150–157, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. K. R. Huber, C. Sebesta, and K. Bauer, “Detection of common hepatitis C virus subtypes with a third-generation enzyme immunoassay,” Hepatology, vol. 24, no. 3, pp. 471–473, 1996. View at Publisher · View at Google Scholar · View at Scopus
  14. G. G. Gensini, “A more meaningful scoring system for determining the severity of coronary heart disease,” The American Journal of Cardiology, vol. 51, no. 3, p. 606, 1983. View at Publisher · View at Google Scholar · View at Scopus
  15. I. J. Neeland, R. S. Patel, P. Eshtehardi et al., “Coronary angiographic scoring systems: an evaluation of their equivalence and validity,” American Heart Journal, vol. 164, no. 4, pp. 547–552.e1, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. P. K. Shah, “Link between infection and atherosclerosis: who are the culprits: viruses, bacteria, both, or neither?” Circulation, vol. 103, no. 1, pp. 5–6, 2001. View at Publisher · View at Google Scholar · View at Scopus
  17. L. E. Adinolfi, L. Restivo, R. Zampino et al., “Chronic HCV infection is a risk of atherosclerosis. Role of HCV and HCV-related steatosis,” Atherosclerosis, vol. 221, no. 2, pp. 496–502, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Ishizaka, N. Ishizaka, E. Takahashi et al., “Association between hepatitis C virus core protein and carotid atherosclerosis,” Circulation Journal, vol. 67, no. 1, pp. 26–30, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. G. Targher, L. Bertolini, R. Padovani, S. Rodella, G. Arcaro, and C. Day, “Differences and similarities in early atherosclerosis between patients with non-alcoholic steatohepatitis and chronic hepatitis B and C,” Journal of Hepatology, vol. 46, no. 6, pp. 1126–1132, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. C. M. Arcari, K. E. Nelson, D. M. Netski, F. J. Nieto, and C. A. Gaydos, “No association between hepatitis C virus seropositivity and acute myocardial infarction,” Clinical Infectious Diseases, vol. 43, no. 6, pp. e53–e56, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. A. A. Butt, W. Xiaoqiang, M. Budoff, D. Leaf, L. H. Kuller, and A. C. Justice, “Hepatitis C virus infection and the risk of coronary disease,” Clinical Infectious Diseases, vol. 49, no. 2, pp. 225–232, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. O. Alyan, F. Kacmaz, O. Ozdemir et al., “Hepatitis C infection is associated with increased coronary artery atherosclerosis defined by modified reardon severity score system,” Circulation Journal, vol. 72, no. 12, pp. 1960–1965, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. B. Yelken, N. Gorgulu, Y. Caliskan et al., “Association between chronic hepatitis c infection and coronary flow reserve in dialysis patients with failed renal allografts,” Transplantation Proceedings, vol. 41, no. 5, pp. 1519–1523, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Maruyama, M. Koda, N. Oyake et al., “Myocardial injury in patients with chronic hepatitis C infection,” Journal of Hepatology, vol. 58, no. 1, pp. 11–15, 2013. View at Publisher · View at Google Scholar · View at Scopus